Faith Bumpus
About Faith Bumpus
Faith Bumpus is a Senior Regional Monitor for the Mid-Western Region at Bristol-Myers Squibb and Site Director at Odonate Therapeutics™ in Boynton Beach, Florida, with extensive experience in clinical trials for various cancers.
Company
Faith Bumpus has an extensive career in clinical research and currently works at Bristol-Myers Squibb as a Senior Regional Monitor for the Mid-Western Region. She is also employed at Odonate Therapeutics™ as the Site Director in Boynton Beach, Florida, United States.
Title
Senior Regional Monitor Mid-Western Region and Site Director at Odonate Therapeutics™ in Boynton Beach, Florida.
Education and Expertise
Faith Bumpus has a diverse educational background in nursing and health sciences. She studied at Baptist College of Health Sciences, obtaining a Diploma in Nursing, and attended the Samaritan Hospital School of Nursing. She specializes in the monitoring of Phase I to Phase IV clinical trials, with a focus on Hematology and Oncology, specifically dealing with a wide range of cancers such as Breast, Ovarian, NSCL, Squamous Cell Lung Cancer, Chronic Myelogenous Leukemia, and Pancreatic Cancer. Her expertise includes the use of both chemotherapeutic and biologic agents.
Professional Background
Faith Bumpus has held several key positions in clinical research. Notably, she worked as the Site Director and Regional Director of Clinical Operations at Odonate Therapeutics™. She also served as a Senior Regional CRA at Novartis and as a Contract Site Monitor and Senior Regional Monitor at Bristol-Myers Squibb. Prior roles include Associate Director Clinical Research - Oncology at Collaborative Research Group, RCRA at Kforce, Contract Regional CRA at sanofi-aventis, CRA at PPD, and Regional CRA at Clinsys Clinical Research. She began her career as Director of Clinical Research at Boca Raton Regional Hospital and IMPACT Center at Response Oncology.
Achievements in Clinical Trials
Faith Bumpus has extensive experience in monitoring clinical trials for various cancers, including Breast Cancer, Ovarian Cancer, NSCL Cancer, Squamous Cell Lung Cancer, Chronic Myelogenous Leukemia, and Pancreatic Cancer. Her work spans Phase I to Phase IV trials, and she has been involved in both 1st and 2nd line clinical trials for Pancreatic Cancer. Her focus on Hematology and Oncology clinical trials showcases her comprehensive knowledge in these fields.